药物诱导的库尼斯综合征:最新的新鲜事物
Paula Ollo-Morales1,2, Marta Gutierrez-Niso1, Elena De-la-Viuda-Camino1
1Department of Allergy, Hospital Universitario Araba, Vitoria, Spain.
Current treatment options in allergy
|June 26, 2023
概括
库尼斯综合征 (KS) 是一种危险的过敏反应,导致急性冠状动脉综合征,通常是由抗生素和NSAIDs等药物引起的. 本综述更新了有关药物诱导的KS的知识,提供了诊断和治疗指南.
科学领域:
- 心脏病学 心脏病学
- 过敏学 过敏学
- 药理学 药理学是指药理学的学科.
背景情况:
- 库尼斯综合征 (KS) 是一种危急的疾病,涉及急性冠状动脉综合征 (ACS),是过敏反应的次要原因.
- 药物诱导的KS是一个重要的,往往被诊断不足的医疗紧急情况,药物是主要原因.
研究的目的:
- 为提供药物诱导的库尼斯综合征的最新审查.
- 为药物诱导的KS的诊断和管理提供当前的指南.
- 为从心脏病和过敏学角度管理KS的临床医生巩固实用资源.
主要方法:
- 在过去五年中,综合性文献综述专注于药物诱导的KS.
- 分析有关KS病理生理学,临床表现,诊断方法和治疗策略的数据.
- 综合信息以突出诊断和治疗方案的变化.
主要成果:
- 抗生素和非类固醇抗炎药物 (NSAIDs) 是KS中最常见的药物罪祸首.
- 目前对库尼斯综合征的诊断和治疗方法存在显著的变化.
- 该审查整合了用于管理KS的实际信息.
结论:
- 药物诱导的库尼斯综合征需要及时识别和管理.
- 需要标准化,基于证据的指导方针来改善KS护理.
- 未来的研究应该专注于开发用于以患者为中心的KS管理的验证工具.
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
40
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
208
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
208
Antiepileptic Drugs: Potassium Channel Activators
217
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
217
Desensitization and Tachyphylaxis
1.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.9K
Antihypertensive Drugs: Potassium-Sparing Diuretics
654
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
654
Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K


